Antiobiotic resistance in the current realities of cardiac surgery

  • V. V. Lazoryshynetz National M.M. Amosov Institute of Cardiovascular Surgery National Academy of Medical Sciences of Ukraine
  • S. P. Spysarenko National M.M. Amosov Institute of Cardiovascular Surgery National Academy of Medical Sciences of Ukraine
  • A. A. Krykunov National M.M. Amosov Institute of Cardiovascular Surgery National Academy of Medical Sciences of Ukraine
  • T. A. Malysheva National M.M. Amosov Institute of Cardiovascular Surgery National Academy of Medical Sciences of Ukraine
Keywords: sepsis, cardiac surgery, reserve antibiotics, antibiotic resistance

Abstract

Today microbial resistance to current antibacterial agents is constantly growing. A significant increase in the role of nosocomial factors in patients with primary infection has a negative impact on the results of cardiac surgery.

Materials and methods. The basis of the study is clinical data of 2992 patients, operated on at SI «National Amosov Institute of Cardiovascular Surgery» NAMS of Ukraine from 01.01.2004 to 01.12.2015 yy. The main nosological forms were: infective endocarditis – 2603 (87.0%) patients, sepsis – 132 (4.4%) and patients with bacteremia – 257 (8.6%) patients.

Results and discussion. The rate of pathogen identification was 1497 (50.03%) cases. Gram-positive microflora was identified in 1001 (66.9%) cases, gram-negative pathogens were reported in 359 (24.0%) cases. Fungal flora quotient was 137 (9.1%) cases. The number of resistant strains to antibiotics of reserve group – vancomycin and linezolid - reached 64.3% and 34.2% of cases respectively. In 2015 the proportion of resistant strains to colomycin and fosfomycin reached 65.3% and 44.0% respectively. Over the observed period septic diseases caused by combination of ESKAPE group pathogens and fungal microflora, accompanied by severe organ lesions, were found.

Conclusions. For overcoming antibiotic resistance it was offered: the use of total body controlled hyperthermic perfusion intraoperatively in patients with infective endocarditis; combination of passive immunization and antibiotic therapy; the use of drugs violating the intercellular communication of bacteria.

References

1. Center for Disease Dynamics, Economics & Policy. 2015. State of the World’s Antibiotics, 2015. CDDEP: Washington, D.C.

2. Antibiotic resistance is the quintessential One Health issue / Robinson T. P., Bu D. P., Carrique-Mas J. et al. // Trans R Soc Trop Med Hyg. – 2016. – Vol. 110 (7). – P. 377–380. doi: 10.1093/trstmh/trw048

3. Sixsmith J., Doyle P., D’Eath M., Barry M. M. Health communication and its role in the prevention and control of communicable diseases in Europe – Current evidence, practice and future developments. Stockholm: ECDC; 2014.

4. O’Neill J. Tackling drug-resistant infections globally: Final report and recommendations. – The review on antimicrobial resistance; London : HM Government and the Wellcome Trust; 2016.

5. Antibiotic Resistance-The Need for Global Solutions / Laxminarayan R., Duse A., Wattal C. et al. // The Lancet Infectious Diseases. – 2013. – Vol. 13 (12). – P. 1057–98.

6. European Survey on Principles of Prudent Antibiotic Prescribing Teaching in Undergraduate Students / Pulcini C., Wencher F., Frimodt-Moller N. et al. // Clinical Microbiology and Infection. – 2014. – Vol. 21 (4). – P. 354–61.

7. Sneeringer S. 2014. The Economics of Sub-Therapeutic Antibiotic Use in U.S. Livestock Agriculture. Paper presented at the Antibiotic Resistance at the Animal-Human Interface Workshop, Princeton University, New Jersey, May 13.
Published
2017-05-15
How to Cite
Lazoryshynetz, V. V., Spysarenko, S. P., Krykunov, A. A., & Malysheva, T. A. (2017). Antiobiotic resistance in the current realities of cardiac surgery. Ukrainian Journal of Cardiovascular Surgery, (1 (27), 110-114. Retrieved from http://cvs.org.ua/index.php/ujcvs/article/view/189
Section
GENERAL ISSUES of CARDIOVASCULAR SURGERY